chartexchange

APRE
Aprea Therapeutics, Inc. Common stock
stockNASDAQ

Market OpenNov 16, 2026 10:00:07 AM EST
0.43USD+2.427%(+0.01)75,736
Pre-marketNov 16, 2026 8:24:30 AM EST
0.428USD+2.835%(+0.012)
0.3500Bid0.5200Ask0.1700Spread

APRE Financials

In Q3 FY 2026 (ended ), Aprea Therapeutics, Inc. Common stock (APRE) reported net income of −$4.81M, operating cash flow of −$3.73M, and assets of $38.81M (filed ).

Loading financial statements…